XML 57 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):

									Three Months Ended March 31,
															2024						2023
Basic:
Net income attributable to Edwards Lifesciences Corporation															$	351.9					$	340.5
Weighted-average shares outstanding															601.6						607.5
Basic earnings per share															$	0.58					$	0.56
Diluted:
Net income attributable to Edwards Lifesciences Corporation															$	351.9					$	340.5
Weighted-average shares outstanding															601.6						607.5
Dilutive effect of stock plans															2.5						3.4
Dilutive weighted-average shares outstanding															604.1						610.9
Diluted earnings per share															$	0.58					$	0.56

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration